5 November 2023
RNZ's Kim Hill discusses the results of the Malaghan Institute's phase 1 clinical trial.
Michele Leggott / Dr Robert Weinkove / Prof Carl June
Results have been released for Malaghan Institute's ground-breaking CAR T-cell cancer therapy trial, and they are promising.
The therapy reprogrammes a patient's own immune cells to recognise and kill cancer.
Discussing the treatment and trial are Professor Carl June from the University of Pennsylvania who pioneered the therapy and Dr Robert Weinkove, who leads Malaghan's CAR T-cell programme.
They are joined by writer and poet Michele Leggott, who is twelve months into the trial, for an update on her progress.
Related articles
Significant milestone reached in first NZ CAR T-cell trial as preparations made for larger phase 2 registration trial
25 March 2024
Read more
BioOra appoints CAR T-cell therapy pioneer, Professor Carl June to Board
31 October 2023
Read more
In Focus: Mastering the technology behind automated CAR T-cell manufacture
14 September 2023
Read more
RNZ: New Zealand developed cancer treatment one step closer to market
17 May 2023
Read more
Malaghan PhD student receives Māori Cancer Researcher Award
28 April 2023
Read more
RNZ: Poet Michele Leggott - waiting for a miracle
8 April 2023
Read more